(IN BRIEF) Sanofi has simplified its contractual arrangements with AstraZeneca and Sobi for the development and commercialization of Beyfortus (nirsevimab)…
(PRESS RELEASE) GENEVA, 29-Apr-2022 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the company…
(COMMUNIQUÉ DE PRESSE) GENEVA, 29-Apr-2022 — /EuropaWire/ — SGS, le leader mondial des tests, de l'inspection et de la certification,…
Further strengthens core R&D areas of autoimmune and allergic diseases Provides full control of brain-penetrant BTK inhibitor SAR442168 in multiple…